Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma

NCT00644306 is registered in ClinicalTrials.gov with Central Hospital, Nancy, France as lead sponsor.

NCT NCT00644306
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00644306 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparison of Melphalan-Prednisone (MP) to MP Plus Thalidomide in the Treatment of Newly Diagnosed Very Elderly Patients (> 75 Years) With Multiple Myeloma
Lead sponsor
Central Hospital, Nancy, France
Phase
Phase 3
Overall status
Terminated
Start date
April 30, 2002
Completion date
May 31, 2007
Enrollment
232 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

newly diagnosed, multiple myeloma